Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Altimmune (ALT) Accumulated Depreciation & Amortization: 2011-2024

Historic Accumulated Depreciation & Amortization for Altimmune (ALT) over the last 1 years, with Dec 2024 value amounting to $2.2 million.

  • Altimmune's Accumulated Depreciation & Amortization rose 12.05% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.8 million, marking a year-over-year increase of 2.50%. This contributed to the annual value of $2.2 million for FY2024, which is 12.05% up from last year.
  • Altimmune's Accumulated Depreciation & Amortization amounted to $2.2 million in Q4 2024, which was up 12.05% from $2.0 million recorded in Q4 2023.
  • Altimmune's 5-year Accumulated Depreciation & Amortization high stood at $2.2 million for Q4 2024, and its period low was $1.1 million during Q1 2022.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $1.7 million (2022), whereas its average is $1.7 million.
  • Per our database at Business Quant, Altimmune's Accumulated Depreciation & Amortization slumped by 36.08% in 2022 and then spiked by 31.84% in 2023.
  • Altimmune's Accumulated Depreciation & Amortization (Quarterly) stood at $1.6 million in 2020, then increased by 28.03% to $2.0 million in 2021, then declined by 26.82% to $1.5 million in 2022, then spiked by 31.84% to $2.0 million in 2023, then rose by 12.05% to $2.2 million in 2024.
  • Its last three reported values are $2.2 million in Q4 2024, $2.0 million for Q4 2023, and $1.5 million during Q4 2022.